A Look Inside Trump's 4-Point Plan For Curbing Drug Prices

By Tom Bulleit and Kirsten Mayer (May 17, 2018, 1:58 PM EDT) -- On May 11, President Donald Trump outlined his administration's four-point plan for curbing prescription drug prices. With rare exceptions, the plan does nothing that will have immediate or even short-term effects, and missing is any reference to the presidents' campaign suggestions of direct federal price negotiation with drugmakers. Instead, the president is calling on the executive branch and, where necessary, Congress, to (1) consider (the blueprint uses the phrase "U.S. Department of Health and Human Services may"), or (2) gather more information about, the merits of taking more modest future steps that he believes will:

Improve competition; Create a framework for better...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!